funder-graph

FundersORPediatric Dermatology Research Alliance Inc › 2024

Grants paid by Pediatric Dermatology Research Alliance Inc, tax year 2024

EIN 84-2173231 · Portland, OR · Form 990, Schedule I · NTEE G03

In tax year 2024, Pediatric Dermatology Research Alliance Inc (EIN 84-2173231) reported 13 grants paid totaling $314,000. Dataset version 2026.09.0, built 2026-09-03.

2019202020212022202320242025

Every grant, 2024

Grants reported by Pediatric Dermatology Research Alliance Inc for tax year 2024
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Phoenix Children's Hospital Phoenix, AZA$65,000paidDEVELOPING A COLLABORATIVE NETWORK AND PATIENT DRIVEN PHYSICIAN VERIFIED REGISTRY FOR FURTHERING THE SCIENCE OF CONGENITAL MELANOCYTIC NEVI (CMN) AND IMPROVING PATIENT OUTCOMES202501329349301810
2024Children's National Hospital Washington, DCA$40,000paidPHENOTYPING HIDRADENITIS SUPPURATIVA IN PEDIATRIC PATIENTS202501329349301810
2024Northwestern University Evanston, ILA$37,500paidUSING DUPILUMAB TO IMPROVE CIRCADIAN FUNCTION, SLEEP AND PRURITUS IN CHILDREN WITH MODERATE/SEVERE ATOPIC DERMATITIS202501329349301810
2024Massachusetts General Boston, MAA$30,000paidNON-INVASIVE GENOMIC TESTING OF LARGE AND GIANT CONGENITAL NEVI202501329349301810
2024Icahn School of Medicine New York, NYA$25,000paidDEFINING PREDICTIVE NONINVASIVE BIOMARKERS FOR PEDIATRIC ATOPIC DERMATITIS PATIENTS202501329349301810
2024University of Colorado School of Medicine Aurora, COA$25,000paidDEVELOPING AN ACNE PATIENT DECISION AID WITH AND FOR HISPANIC TEENAGERS202501329349301810
2024Emory University Atlanta, GAA$25,000paidACNE INCIDENCE AND TREATMENT IN TRANSGENDER ADOLESCENTS: A MULTI-CENTER, VALIDATED COHORT STUDY202501329349301810
2024Johns Hopkins University Baltimore, MDA$25,000paidLONG-TERM MANAGEMENT OF SYSTEMIC TREATMENTS FOR PEDIATRIC ATOPIC DERMATITIS: A PILOT CLINICAL TRIAL AND MULTI-CENTER REGISTRY DEVELOPMENT202501329349301810
2024Cincinnati Children's Hospital Cincinnati, OHA$10,000paidCONSENSUS STATEMENT ON PULSED-DYE LASER TREATMENT FOR PORT-WINE BIRTHMARKS202501329349301810
2024Duke University Durham, NCA$10,000paidDRUG SURVIVAL OF BIOLOGICS IN PEDIATRIC PATIENTS WITH HIDRADENITIS SUPPURATIVA SEEN AT DUKE, MGH AND UMASS MEMORIAL HEALTH202501329349301810
2024Washington University in St Louis Stlouis, MOA$7,500paidMAPPING THE CONGENITAL MELANOCYTIC NEVUS (CMN) REMOVAL JOURNEY: INSIGHTS FROM PATIENTS, FAMILIES, AND CLINICIANS202501329349301810
2024National Institutes of Health Bethesda, MDA$7,500paidINVESTIGATING THE PREVALENCE OF INBORN ERRORS OF IMMUNITY AND TREATMENT RESPONSES IN PEDIATRIC ALOPECIA AREATA: A MULTI-SITE STUDY202501329349301810
2024Dartmouth Hitchcock Health Lebanon, NHA$6,500paidAN ANALYSIS OF LOCAL TREATMENT AVENUES FOR CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS: A SYSTEMATIC REVIEW & META-ANALYSIS202501329349301810

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.